1. Home
  2. CRVL vs ARQT Comparison

CRVL vs ARQT Comparison

Compare CRVL & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRVL
  • ARQT
  • Stock Information
  • Founded
  • CRVL 1987
  • ARQT 2016
  • Country
  • CRVL United States
  • ARQT United States
  • Employees
  • CRVL N/A
  • ARQT N/A
  • Industry
  • CRVL Specialty Insurers
  • ARQT Biotechnology: Pharmaceutical Preparations
  • Sector
  • CRVL Finance
  • ARQT Health Care
  • Exchange
  • CRVL Nasdaq
  • ARQT Nasdaq
  • Market Cap
  • CRVL 1.9B
  • ARQT 1.7B
  • IPO Year
  • CRVL 1991
  • ARQT 2020
  • Fundamental
  • Price
  • CRVL $112.51
  • ARQT $13.53
  • Analyst Decision
  • CRVL
  • ARQT Strong Buy
  • Analyst Count
  • CRVL 0
  • ARQT 6
  • Target Price
  • CRVL N/A
  • ARQT $18.80
  • AVG Volume (30 Days)
  • CRVL 159.3K
  • ARQT 2.1M
  • Earning Date
  • CRVL 05-21-2025
  • ARQT 05-06-2025
  • Dividend Yield
  • CRVL N/A
  • ARQT N/A
  • EPS Growth
  • CRVL 18.07
  • ARQT N/A
  • EPS
  • CRVL 1.70
  • ARQT N/A
  • Revenue
  • CRVL $871,308,000.00
  • ARQT $212,819,000.00
  • Revenue This Year
  • CRVL N/A
  • ARQT $57.99
  • Revenue Next Year
  • CRVL N/A
  • ARQT $41.24
  • P/E Ratio
  • CRVL $66.14
  • ARQT N/A
  • Revenue Growth
  • CRVL 12.64
  • ARQT 100.03
  • 52 Week Low
  • CRVL $76.53
  • ARQT $6.99
  • 52 Week High
  • CRVL $128.61
  • ARQT $17.75
  • Technical
  • Relative Strength Index (RSI)
  • CRVL 52.62
  • ARQT 42.73
  • Support Level
  • CRVL $109.53
  • ARQT $12.42
  • Resistance Level
  • CRVL $114.00
  • ARQT $15.67
  • Average True Range (ATR)
  • CRVL 2.85
  • ARQT 0.84
  • MACD
  • CRVL 0.03
  • ARQT -0.07
  • Stochastic Oscillator
  • CRVL 55.82
  • ARQT 34.15

About CRVL CorVel Corp.

CorVel Corp applies technology including artificial intelligence, machine learning and natural language processing to enhance the managing of episodes of care and the related health care costs. It partners with employers, third-party administrators, insurance companies and government agencies in managing worker's compensation and health, auto and liability services. The company's solutions combine integrated technologies with a human touch. CorVel's customized services, delivered locally, are backed by a national team to support clients as well as their customers and patients.

About ARQT Arcutis Biotherapeutics Inc.

Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.

Share on Social Networks: